INVESTIGAR Act

Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure Prescription Drug Supply Chain issues Pharmacy benefit manager policies H.R.7635, The 340B PATIENTS Act of 2024, Entirety H.R.8574, 340B ACCESS Act, Entirety H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety The SUSTAIN 340B Act, Entirety 340B payment process issues 340B Reform related issues Monitor the following: Native American health workforce development issues, generally FDA, Diagnostic Laboratory Testing issues Health Care Price Transparency H.$.5378, Lower Cost More Transparency Act, Entirety H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Mental Health initiatives Center for Excellence in Improving Diagnosis legislation Surprise Billing Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3465, Iran China Accountability Act, all provisions. H.R. 7635, INVESTIGAR Act, all provisions. H.R. 7824, Taylor Force Martyr Payment Prevention Act of 2022, all provisions. H.R. 7851, To Amend the Higher Education Act of 1965 to Require Institutions of Higher Education to Disclose Certain Ties to China-Affiliated Organizations, and for Other Purposes, all provisions. H.R. 7998, Sanctioning Supporters of Slave Labor Act, all provisions. H.R. 8001, Countering Atrocities through Currency Accountability Act of 2022, all provisions. H.R. 8282, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2023, (issues related to Chinese Influence Operations in the U.S., Middle East Consortium on Infection Disease Surveillance, International and Multilateral Organizations, Anti-Semitism, U.S. Policy on Israel, U.S. Policy on Iran, UN Procurement from Russia). S. 4290, Iran China Accountability Act, all provisions. S. 4554, Iran Nuclear Weapons Capability Monitoring Act of 2022, all provisions. S.4389, COI Elimination Act, all provisions. Issues related to Chinese Influence Operations, Congressional Oversight of U.S. Foreign Assistance, Implementation of the Caesar Syria Civilian Protection Act, Implementation of the Iran Nuclear Agreement Review Act, International and Multilateral Organizations, Iran Sanctions, Iran's Foreign Policy and Military Strategy, Normalization in the Middle East, Palestinian Politics and Terrorism, Syria Sanctions, Technology Export Controls, U.S. Counterterrorism Policy, U.S. Cybersecurity Strategy and Capabilities, U.S. Policy on China, U.S. Policy on Iran, U.S. Policy on Iraq, U.S. Policy on Narcotics Trafficking, U.S. Policy on North Korea, U.S. Policy on Qatar, U.S. Policy on Russia, U.S. Policy on Saudi Arabia, U.S. Policy on Syria, U.S. Policy on Taiwan, U.S. Policy on the Indo-Pacific, U.S. Policy on Turkey, U.S. Policy on Ukraine (no bill).

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of